Even after controlling for factors that might affect medication choice, researchers found that the odds of newer medication use was associated with race.
Early results from the PERPRISE study showed high retention and seizure-freedom rates among adults with focal or idiopathic generalized epilepsy who received perampanel as add-on therapy.
A new study provides more reassurance that in utero exposure to antiseizure medications are safe and do not have a negative effect on children s cognition.